Chinese electric-vehicle maker NIO's shares rose sharply after its new ES9 sports utility vehicle launch with a lower-than-expected price tag. Its shares rose 8.4% in early Thursday, trading to 45.24 ...
Eight months after being awarded the project by the French State, TotalEnergies' wholly owned project company Centre Manche Energies has officially applied for the Single Authorization of the 1.5 GW ...
Avolta said it won a 12-year contract to operate retail and food-and-beverage outlets at Riga Airport in Latvia. The Swiss company, which operates stores at airports and other travel hubs, said ...
By Yukiho Takaichi / Yomiuri Shimbun Staff Writer Major Japanese household goods maker Lion Corp. plans to expand sales of high-margin oral care products as part of efforts to cope with the naphtha ...
Banco Santander said it completed an issue of $1.5 billion in financial instruments contingently convertible into shares. The Spanish bank said late Wednesday that the instruments would be eligible as ...
The number of 401(k) millionaires just fell — but workers hit record savings rates. What’s going on?
Retirement account balances fell in the first quarter amid broad market weakness, cutting the number of 401(k) millionaires — ...
U.S. forces carried out new strikes on Wednesday on an Iran military facility after downing Iranian attack drones, according ...
Shares of Workhorse Group Inc. WKHS rallied 8.82% to $3.70 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising ...
Equities had been prone to larger upswings when President Trump previously talked positively about the two sides getting ...
Shares of Target Hospitality retreated after the company said seven million shares of its common stock are now available in a secondary offering. The remote workforce accommodations and hospitality ...
China’s next export shock may not arrive in a shipping container — it may walk onto the factory floor. For years, the world ...
Abbvie received approval from the Food and Drug Administration for its drug treating people with a rare form of blood cancer. Decnupaz was approved to treat adults with Blastic Plasmacytoid Dendritic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results